Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,721 to 1,740 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hidden Aspects of Valency in Immune System Regulation. | Trends Immunol | 2019 | 31734148 | PubTator, text mining | PubMed |
| Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies. | Immunol Rev | 2019 | 31721234 | PubTator, text mining | PubMed |
| IRAK1 and IRAK4 signaling proteins are dispensable in the response of human neutrophils to Mycobacterium tuberculosis infection. | FEMS Microbiol Lett | 2019 | 31702785 | PubTator, text mining | PubMed |
| MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications. | Haematologica | 2019 | 31699794 | PubTator, text mining | PubMed |
| Evaluating ibrutinib in the treatment of symptomatic Waldenstrom's macroglobulinemia. | J Blood Med | 2019 | 31695539 | PubTator, text mining | PubMed |
| Distinct signals and immune cells drive liver pathology and glomerulonephritis in ABIN1[D485N] mice. | Life Sci Alliance | 2019 | 31694920 | PubTator, text mining | PubMed |
| Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection. | Pharmacol Res | 2019 | 31689522 | PubTator, text mining | PubMed |
| Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention. | Front Pediatr | 2019 | 31681706 | PubTator, text mining | PubMed |
| Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists. | Front Immunol | 2019 | 31681325 | PubTator, text mining | PubMed |
| IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activity. | Sci Rep | 2019 | 31664109 | PubTator, text mining | PubMed |
| Perivascular Stem Cells Suppress Inflammasome Activation during Inflammatory Responses in Macrophages. | Int J Stem Cells | 2019 | 31658511 | PubTator, text mining | PubMed |
| Deleterious Variants in WNT10A, EDAR, and EDA Causing Isolated and Syndromic Tooth Agenesis: A Structural Perspective from Molecular Dynamics Simulations. | Int J Mol Sci | 2019 | 31652981 | PubTator, text mining | PubMed |
| The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox. | Int J Mol Sci | 2019 | 31652497 | PubTator, text mining | PubMed |
| Assessing the role of toll-like receptor in isolated, standard and enriched housing conditions. | PLoS One | 2019 | 31647818 | PubTator, text mining | PubMed |
| Transient up-regulation of miR-155-3p by lipopolysaccharide in primary human monocyte-derived macrophages results in RISC incorporation but does not alter TNF expression. | Wellcome Open Res | 2019 | 31641696 | PubTator, text mining | PubMed |
| Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma. | J Med Chem | 2019 | 31622099 | PubTator, text mining | PubMed |
| PROTAC Degradation of IRAK4 for the Treatment of Cancer. | ACS Med Chem Lett | 2019 | 31620217 | PubTator, text mining | PubMed |
| A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease. | Sci Transl Med | 2019 | 31619543 | PubTator, text mining | PubMed |
| At Least Two Genes Encode Many Variants of Irak3 in Rainbow Trout, but Neither the Full-Length Factor Nor Its Variants Interfere Directly With the TLR-Mediated Stimulation of Inflammation. | Front Immunol | 2019 | 31616422 | PubTator, text mining | PubMed |
| Multiple roles of microRNA-146a in immune responses and hepatocellular carcinoma. | Oncol Lett | 2019 | 31612014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=87